Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025
Castle Biosciences (Nasdaq: CSTL) will release financial results for the third quarter and nine months ended Sept. 30, 2025 after market close on Monday, Nov. 3, 2025.
Management will host a conference call and webcast at 4:30 p.m. Eastern the same day. A live webcast is available at the company investor relations site or via https://events.q4inc.com/attendee/153584002. U.S. phone access is 1-833-470-1428 (access code 735311); international numbers are listed at the provided global numbers link. Attendees are asked to connect at least 10 minutes early. A replay will be available after the call and a brief Q&A will follow management remarks.
Castle Biosciences (Nasdaq: CSTL) will release financial results for the third quarter and nine months ended Sept. 30, 2025 after market close on Monday, Nov. 3, 2025.
Management will host a conference call and webcast at 4:30 p.m. Eastern the same day. A live webcast is available at the company investor relations site or via https://events.q4inc.com/attendee/153584002. U.S. phone access is 1-833-470-1428 (access code 735311); international numbers are listed at the provided global numbers link. Attendees are asked to connect at least 10 minutes early. A replay will be available after the call and a brief Q&A will follow management remarks.
Castle Biosciences (Nasdaq: CSTL) divulgará los resultados financieros del tercer trimestre y de los primeros nueve meses terminados el 30 de septiembre de 2025 después del cierre del mercado el lunes 3 de noviembre de 2025.
La dirección organizará una conferencia telefónica y una transmisión web a las 4:30 p.m., hora del Este del mismo día. Una webcast en vivo está disponible en el sitio de relaciones con inversores de la empresa o a través de https://events.q4inc.com/attendee/153584002. El acceso telefónico de EE. UU. es 1-833-470-1428 (código de acceso 735311); los números internacionales figuran en el enlace de números globales proporcionado. Se solicita a los asistentes que se conecten al menos 10 minutos antes. Habrá una repetición después de la llamada y seguirá una breve sesión de preguntas y respuestas.
Castle Biosciences (Nasdaq: CSTL)는 2025년 9월 30일 종료된 3분기 및 9개월의 재무 실적을 2025년 11월 3일 월요일 시장 마감 후 발표합니다.
경영진은 같은 날 동부 시간 오후 4시 30분에 컨퍼런스 콜과 웹캐스트를 개최합니다. 라이브 웹캐스트는 회사의 투자자 관계 사이트에서 또는 https://events.q4inc.com/attendee/153584002를 통해 이용 가능합니다. 미국 전화 접속 번호는 1-833-470-1428(접속 코드 735311); 국제 번호는 제공된 글로벌 번호 링크에 나와 있습니다. 참석자들은 최소 10분 일찍 연결해 주시기 바랍니다. 통화 후 재방송이 제공되며 경영진 발언 뒤 간단한 Q&A가 이어집니다.
Castle Biosciences (Nasdaq : CSTL) divulguera les résultats financiers du troisième trimestre et des neufs premiers mois terminés le 30 septembre 2025 après la clôture du marché le lundi 3 novembre 2025.
La direction animera une conférence téléphonique et une webdiffusion à 16 h 30, heure de l'Est le même jour. Une webdiffusion en direct est disponible sur le site des relations investisseurs de l'entreprise ou via https://events.q4inc.com/attendee/153584002. L'accès téléphonique américain est le 1-833-470-1428 (code d'accès 735311); les numéros internationaux figurent dans le lien des numéros globaux fourni. Les participants sont priés de se connecter au moins 10 minutes avant. Une rediffusion sera disponible après l'appel et une brève session de questions-réponses suivra les remarques de la direction.
Castle Biosciences (Nasdaq: CSTL) wird die finanziellen Ergebnisse für das dritte Quartal und die ersten neun Monate, beendet zum 30. September 2025, nach Börsenschluss am Montag, dem 3. November 2025 bekannt geben.
Das Management wird am selben Tag um 16:30 Uhr Eastern Time einen Konferenzanruf und einen Webcast veranstalten. Ein Live-Webcast ist auf der Investor-Relations-Website des Unternehmens oder über https://events.q4inc.com/attendee/153584002 verfügbar. Der US-Telefonzugang lautet 1-833-470-1428 (Zugangscode 735311); internationale Nummern sind unter dem bereitgestellten Link mit globalen Nummern aufgeführt. Die Teilnehmer werden gebeten, sich mindestens 10 Minuten früher anzumelden. Eine Wiederholung wird nach dem Anruf verfügbar sein, und eine kurze Q&A-Sitzung folgt den Managementbemerkungen.
Castle Biosciences (Nasdaq: CSTL) ستصدر نتائجها المالية للربع الثالث وللثمانية أشهر حتى 30 سبتمبر 2025 بعد إغلاق السوق يوم الإثنين 3 نوفمبر 2025.
ستستضيف الإدارة مكالمة مؤتمريه وبثاً مباشراً في 4:30 مساءً بتوقيت الشرق في اليوم نفسه. تتوفر بث مباشر على موقع علاقات المستثمرين بالشركة أو عبر https://events.q4inc.com/attendee/153584002. الوصول عبر الهاتف الأميركي هو 1-833-470-1428 (رمز الدخول 735311); تُدرج أرقام دولية في الرابط الخاص بالأرقام العالمية المقدم. يُطلب من الحضور الاتصال قبل 10 دقائق على الأقل. سيكون بإمكانكم الحصول على إعادة بث بعد المكالمة وتليها جلسة أسئلة وأجوبة موجزة.
Castle Biosciences (Nasdaq: CSTL) 将在市场收盘后披露截至 2025年9月30日 的第三季度及前九个月的财务业绩，2025年11月3日，星期一。
管理层将于同日举行电话会议和网络直播，时间为美国东部时间下午4:30。现场网络广播可在公司投资者关系网站或通过 https://events.q4inc.com/attendee/153584002 访问。美国电话接入号码为 1-833-470-1428（接入码 735311）；国际号码列在所提供的全球号码链接中。请与会者至少提前10分钟连接。通话结束后将提供重播，管理层发言后将进行简短问答。
- None.
- None.
FRIENDSWOOD, Texas, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the third quarter and nine months ended Sept. 30, 2025, after the close of market on Monday, Nov. 3, 2025.
Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m. Eastern time on the same day.
Conference Call and Webcast Details
A live webcast of the conference call can be accessed here: https://events.q4inc.com/attendee/153584002, or via the webcast link on the Investor Relations page of the Company’s website: https://ir.castlebiosciences.com/overview/default.aspx. Please access the webcast at least 10 minutes before the conference call start time. A replay of the webcast will be available following the conclusion of the conference call.
To access the live conference call via phone, please dial 1 833 470 1428 from the United States, at least 10 minutes prior to the start of the call, using the access code 735311. International dial-in numbers are available here: https://www.netroadshow.com/conferencing/global-numbers?confId=89205; please use the same access code above to join the call.
There will be a brief Question and Answer session following management commentary.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact:
Allison Marshall
amarshall@castlebiosciences.com
Source: Castle Biosciences Inc.
FAQ
When will Castle Biosciences (CSTL) release Q3 2025 results?
What time is the Castle Biosciences (CSTL) conference call on Nov. 3, 2025?
How can investors join the Castle Biosciences (CSTL) webcast on Nov. 3, 2025?
What is the phone access code for the Castle Biosciences (CSTL) conference call?
Will a replay of the Castle Biosciences (CSTL) Nov. 3, 2025 call be available?
Will Castle Biosciences (CSTL) take questions during the Nov. 3, 2025 call?
